PPPeter De Paepe

Peter De Paepe

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Peter De Paepe has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Meropenem Dosing for Pediatric Critical Care Patients: Multisite Pharmacokinetic Study, 2012–2020

    by Anh Thi Van Nguyen, Evelyn Dhont, Zhiyuan Tan, Tatjana Van Der Heggen, Emma Beel, Nick Verougstraete, Veronique Stove, Pieter-Jan De Sutter, Sophie Vanhaesebrouck, Daphné Vania Vens, et al.

    OBJECTIVES: Critically ill children may present with altered pharmacokinetics (PK) and/or pharmacodynamics (PD), leading to suboptimal dosing of meropenem. We aimed to: 1) investigate meropenem PK in critically ill children, 2) identify factors associated with interindividual PK variability, and 3) evaluate the PK/PD target attainment rates of current and alternative dosing strategies against the most used PK/PD targets. DESIGN: Observational PK study with plasma samples taken after the first and steady state doses after receiving IV meropenem. Data were analyzed using nonlinear mixed-effects modeling. Monte Carlo simulations were performed to evaluate the probability of PK/PD target attainment for different dosing strategies within the first 48 hours of treatment. SETTING: Neonatal and PICU of two Belgian tertiary care hospitals, 2012–2020. PATIENTS: Fifty-four critically ill children (7 d to 14.5 yr old) receiving meropenem infusion at 20–40 mg/kg every 6, 8, or 12 hours. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Four hundred twenty-three plasma samples were used for population PK analysis. A two-compartment model with allometric scaling and a sigmoidal maturation function accounting for the effects of growth and development best described the data. The typical values for clearance, central volume of distribution, intercompartmental clearance, and peripheral volume of distribution were 13.1, 12.5, 23.9 L/hr/70 kg, and 16.3 L/70 kg, respectively. A loading dose of 40 mg/kg, followed by a continuous infusion of 60 mg/kg/d, was required to achieve 100% of the time the unbound concentration above the minimum inhibitory concentration (MIC) against Enterobacterales species and Pseudomonas aeruginosa (MIC ≤ 2 mg/L) without compromising safety. CONCLUSIONS: Standard intermittent dosing regimens (20–40 mg/kg every 8 hr over 0.5 hr) are likely to result in subtherapeutic concentrations, thereby risking therapy failure in critically ill children. A loading dose followed by continuous infusion is suggested for optimal target attainment.

  • Reliability of glomerular filtration rate estimating formulas compared to iohexol plasma clearance in critically ill children

    by Evelyn Dhont, Charlotte Windels, Evelien Snauwaert, Tatjana Van Der Heggen, Annick de Jaeger, Laura Dhondt, Joris Delanghe, Siska Croubels, Johan Vande Walle, Peter De Paepe, et al.

    Accurate renal function assessment is crucial to guide intensive care decision-making and drug dosing. Estimates of glomerular filtration rate (eGFR) are routinely used in critically ill children; however, these formulas were never evaluated against measured GFR (mGFR) in this population. We aimed to assess the reliability of common eGFR formulas compared to iohexol plasma clearance (CLiohexol) in a pediatric intensive care (PICU) population. Secondary outcomes were the prevalence of acute kidney injury (AKI) (by pRIFLE criteria) and augmented renal clearance (ARC) (defined as standard GFR for age + 2 standard deviations (SD)) within 48 h after admission based on mGFR and eGFR by the revised Schwartz formula and the difference between these two methods to diagnose AKI and ARC. In children, between 0 and 15 years of age, without chronic renal disease, GFR was measured by CLiohexol and estimated using 26 formulas based on creatinine (Scr), cystatine C (CysC), and betatrace protein (BTP), early after PICU admission. eGFR and mGFR results were compared for the entire study population and in subgroups according to age, using Bland–Altman analysis with calculation of bias, precision, and accuracy expressed as percentage of eGFR results within 30% (P30) and 10% (P10) of mGFR. CLiohexol was measured in 98 patients. Mean CLiohexol (± SD) was 115 ± 54 ml/min/1.73m2. Most eGFR formulas showed overestimation of mGFR with large bias and poor precision reflected by wide limits of agreement (LoA). Bias was larger with CysC- and BTP-based formulas compared to Scr-based formulas. In the entire study population, none of the eGFR formulas showed the minimal desired P30 > 75%. The widely used revised Schwartz formula overestimated mGFR with a high percentage bias of − 18 ± 51% (95% confidence interval (CI) − 29; − 9), poor precision with 95% LoA from − 120 to 84% and insufficient accuracy reflected by P30 of only 51% (95% CI 41; 61), and P10 of 21% (95% CI 13; 66) in the overall population. Although performance of Scr-based formulas was worst in children below 1 month of age, exclusion of neonates and younger children did not result in improved agreement and accuracy. Based on mGFR, prevalence of AKI and ARC within 48 h was 17% and 45% of patients, respectively. There was poor agreement between revised Schwartz formula and mGFR to diagnose AKI (kappa value of 0.342, p < 0.001; sensitivity of 30%, 95% CI 5; 20%) and ARC (kappa value of 0.342, p < 0.001; sensitivity of 70%, 95% CI 33; 58). Conclusion: In this proof-of-concept study, eGFR formulas were found to be largely inaccurate in the PICU population. Clinicians should therefore use these formulas with caution to guide drug dosing and therapeutic interventions in critically ill children. More research in subgroup populations is warranted to conclude on generalizability of these study findings. ClinicalTrials.gov NCT05179564, registered retrospectively on January 5, 2022. What is Known: • Both acute kidney injury and augmented renal clearance may be present in PICU patients and warrant adaptation of therapy, including drug dosing. • Biomarker-based eGFR formulas are widely used for GFR assessment in critically ill children, although endogenous filtration biomarkers have important limitations in PICU patients and eGFR formulas have never been validated against measured GFR in this population. What is New: • eGFR formulas were found to be largely inaccurate in the PICU population when compared to measured GFR by iohexol clearance. Clinicians should therefore use these formulas with caution to guide drug dosing and therapeutic interventions in critically ill children. • Iohexol plasma clearance could be considered an alternative for accurate GFR assessment in PICU patients.


  • Open Access

    Combined oropharyngeal/nasal swab is equivalent to nasopharyngeal sampling for SARS-CoV-2 diagnostic PCR

    by Tania Desmet, Peter De Paepe, Jerina Boelens, Liselotte Coorevits, Elizaveta Padalko, Stien Vandendriessche, Isabel Leroux-Roels, Annelies Aerssens, Steven Callens, Eva Van Braeckel, et al.

    Background: Early 2020, a COVID-19 epidemic became a public health emergency of international concern. To address this pandemic broad testing with an easy, comfortable and reliable testing method is of utmost concern. The nasopharyngeal (NP) swab sampling is the reference method though hampered by international supply shortages. A new oropharyngeal/nasal (OP/N) sampling method was investigated using the more readily available throat swab. Methods: In this prospective observational study 36 COVID-19 patients were tested with both a NP and combined OP/N swab for SARS-CoV-2 RNA by PCR. In hospitalized suspect patients, who tested negative on both swabs, extensive retesting was performed. The sensitivity of NP versus combined OP/N swab sampling on admission and the correlation between viral RNA loads recovered was investigated. Results: 35 patients were diagnosed with SARS-CoV-2 by means of either NP or OP/N sampling. The paired swabs were both positive in 31 patients. The one patient who tested negative on both NP and OP/N swab on admission, was ultimately diagnosed on bronchoalveolar lavage fluid. A strong correlation was found between the viral RNA loads of the paired swabs (r = 0.76; P < 0.05). The sensitivity of NP and OP/N analysis in hospitalized patients (n = 28) was 89.3% and 92.7% respectively. Conclusions: This study demonstrates equivalence of NP and OP/N sampling for detection of SARS-CoV-2 by means of rRT-PCR. Sensitivity of both NP and OP/N sampling is very high in hospitalized patients.